arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

CRISPR Therapeutics AG

CRSP Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$51.84
▼ -9.0% Today
as of Jun 7, 07:12 ET
Last 30 days -0.42% Apr 28 → Jun 05
$46.84 $49.56 $52.27 $54.98 $57.70 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$55.99
High
$55.76
Low
$51.15
Volume
$2M
Avg Vol
$2M
Mkt Cap
$5.4B
P/E (TTM)
Beta
52w High
$78.48
52w Low
$37.02
Div Yield
Shares Out
$96M

Overview

52-week range
$37
$78
36% of range
Avg surprise (last 2)
-18.3%
Avg reaction (last 2)
-4.0%
50% positive
Latest IV / EM
72%
EM ±6.7% · $52 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.40$-2.04$-1.69$-1.33$-0.98 Actual $-0.98Actual $-1.41Actual $-1.43Actual $-1.49Actual $-1.01Actual $-1.58Est $-1.27Actual $-2.40Actual $-1.17Actual $-1.28Est $-1.14 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-209M$-179M$-149M$-120M$-90M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 4, 2026Mar/2026 $-1.28 $-1.14 -12.3% +19.0% +3.8% earnings
Tue Sep 30, 2025Sep 2025 $-1.17 financials
Mon Jun 30, 2025Jun 2025 $-2.40 financials
Tue May 6, 2025Mar/2025 $-1.58 $-1.27 -24.4% -11.9% earnings
Mon Sep 30, 2024Sep 2024 $-1.01 financials
Sun Jun 30, 2024Jun 2024 $-1.49 financials
Sun Mar 31, 2024Mar 2024 $-1.43 financials
Sat Sep 30, 2023Sep 2023 $-1.41 financials
Fri Jun 30, 2023Jun 2023 $-0.98 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-130M$-132M$-229M$-148M$-110M$-151M
Net income$-123M$-106M$-209M$-136M$-86M$-126M
EPS (diluted)$-1.28$-1.17$-2.40$-1.58$-1.01$-1.49

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$423M$348M$286M$194M$235M$298M$226M$484M
Inventory
Total current assets$2.45B$1.99B$1.93B$1.73B$1.87B$1.94B$1.94B$2.01B
Total assets$2.73B$2.27B$2.25B$2.03B$2.17B$2.24B$2.26B$2.34B
Long-term debt$585M$0
Total liabilities$911M$343M$329M$319M$337M$310M$316M$359M
Total equity$1.81B$1.92B$1.92B$1.71B$1.83B$1.93B$1.94B$1.98B

Implied volatility — last 90 days

66%69%71%74%76% Jun 07 — IV 72% · EM ±6.7%

Sector peers